Back to search

Article

GLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes Mellitus

2026-07-06

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Glucagon-like peptide-1 receptor agonist-based therapies (GLP) have recently emerged as promising treatments across a wide range of health conditions. These medications may have protective effects against severe long-term consequences of COVID-19 by promoting weight loss, exerting antihyperglycemic and anti-inflammatory effects, and providing cardiovascular and endothelial p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6b216a48-113a-5834-a0c5-ac3ebb90169b
DOI
10.64898/2026.07.03.26357246
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes MellitusDOI 10.64898/2026.07.03.26357246
Metformin and Severe Post-COVID-19 Outcomes Among Individuals with Diabetes MellitusSemantic proximity
Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.Semantic proximity
Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us.Semantic proximity
Risk Phenotypes of Diabetes and Association with COVID-19 Severity and Death – A Living Systematic Review and Meta-AnalysisSemantic proximity
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.Semantic proximity
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudySemantic proximity
Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary careSemantic proximity
Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetesSemantic proximity
Type 1 and Type 2 Diabetes and COVID-19 Related Mortality in England: A Whole Population StudySemantic proximity
GLP1R gene expression is associated with metabolic and mental health effects in a phenome-wide drug repurposing and safety analysisSemantic proximity
The impact of COVID-19 illness on metabolic phenotypes underlying type 2 diabetes mellitus: a systematic review.Semantic proximity
Association of COVID-19 with Diabetes: A Systematic Review and Meta-AnalysisSemantic proximity
Select a neighboring publication to make it the new centre.